126 related articles for article (PubMed ID: 14129631)
21. [DESFERRIOXAMINE WITH CORTICOSTEROIDS IN A CASE OF IDIOPATHIC PULMONARY HEMOSIDEROSIS].
CAVALIERI S
Fracastoro; 1963; 56():389-403. PubMed ID: 14117876
[No Abstract] [Full Text] [Related]
22. CLINICAL STUDIES OF STORAGE IRON WITH DESFERRIOXAMINE.
GEVIRTZ NR; TENDLER D; LURINSKY G; WASSERMAN LR
N Engl J Med; 1965 Jul; 273():95-7. PubMed ID: 14301206
[No Abstract] [Full Text] [Related]
23. [TREATMENT OF HEMOSIDEROSIS SECONDARY TO MULTIPLE TRANSFUSIONS, WITH SPECIAL REFERENCE TO COOLEY'S HEMOLYTIC ANEMIA].
RITTER M
Hospital (Rio J); 1964 Oct; 66():861-6. PubMed ID: 14226293
[No Abstract] [Full Text] [Related]
24. Iron overload in cardiac valvular disease and pure red cell aplasia: treatment with desferrioxamine.
Hehlmann R; Schmitz H; Krüger K
Int J Cardiol; 1984 Jun; 5(6):749-53. PubMed ID: 6235195
[TBL] [Abstract][Full Text] [Related]
25. SUBSTITUTIVE-INHIBITORY THERAPY IN CONSTITUTIONAL NON-SPHEROCYTIC ERYTHROCYTIC DISEASE.
REWALD E
Acta Haematol; 1964 May; 31():303-9. PubMed ID: 14172699
[No Abstract] [Full Text] [Related]
26. [RESEARCH ON DESFERRIOXAMINE B. 3. THE CLINICAL USE OF DESFERRIOXAMINE B].
VENTURA S; COLI L
Haematologica; 1964; 49():252-73. PubMed ID: 14217827
[No Abstract] [Full Text] [Related]
27. Desferal therapy in iron storage disease.
Thompson RB; Owen DM; Bell WN
Am J Med Sci; 1967 Apr; 253(4):453-60. PubMed ID: 6021380
[No Abstract] [Full Text] [Related]
28. [Continuous subcutaneous desferrioxamine infusions in patients with hemosiderosis (author's transl)].
Tillmann W; König R; Schröder K; Schröter W
Monatsschr Kinderheilkd; 1982 Mar; 130(3):171-2. PubMed ID: 7087975
[No Abstract] [Full Text] [Related]
29. Iron metabolism and chelation therapy in hemosiderosis.
Graziano JH
Curr Top Hematol; 1978; 1():127-50. PubMed ID: 400529
[No Abstract] [Full Text] [Related]
30. [PRELIMINARY RESULTS OF THE USE OF DESFERRIOXAMINE B (DESF'ERAL CIBA) IN THE TREATMENT OF STATES OF IRON OVERLOADING IN SOME BLOOD DISEASES IN INFANCY].
CHAPTAL J; JEAN R; CRASTESDEPAULET A; BONNET H; NAVARRO M; LLORET R
Montp Med; 1965; 67():15-28. PubMed ID: 14329617
[No Abstract] [Full Text] [Related]
31. Evaluation of continuous desferrioxamine administration in adults with transfusional hemosiderosis.
Cooper B; Bunn HF; Propper RD; Nathan DG; Rosenthal DS; Moloney WC
Trans Assoc Am Physicians; 1977; 90():335-41. PubMed ID: 611665
[No Abstract] [Full Text] [Related]
32. Transfusion haemosiderosis inspite of regular use of desferrioxamine: case report.
Mwanda OW; Otieno CF; Abdalla FK
East Afr Med J; 2004 Jun; 81(6):326-8. PubMed ID: 16167682
[TBL] [Abstract][Full Text] [Related]
33. [A CASE OF ACUTE APLASTIC ANEMIA ASSOCIATED WITH APLASTIC BONE NARROW].
INOUE K; YAMABE H
Naika Hokan; 1964 Aug; 11():368-74. PubMed ID: 14214528
[No Abstract] [Full Text] [Related]
34. [THE USE OF DESFERRIOXAMINE IN THE TREATMENT OF SIDEROBLASTIC ANEMIAS].
PUECH A; IZARN P; OLIVIER G; DERMENCHEM M; EMBERGER JM; PILON R
Montp Med; 1965; 67():1-14. PubMed ID: 14329618
[No Abstract] [Full Text] [Related]
35. [APLASTIC ANEMIA ASSOCIATED WITH SERUM HEPATITIS, HEMOSIDEROSIS AND GLYCOSURIA].
YAGIRI Y; KYOGOKU M; MIYAZAKI A
Naika Hokan; 1964 Mar; 11():129-36. PubMed ID: 14163644
[No Abstract] [Full Text] [Related]
36. [A case of Diamond-Blackfan anemia: Experiences of 10-year follow-up study].
Vadász G
MMW Munch Med Wochenschr; 1974 Nov; 116(47):2077-80. PubMed ID: 4216814
[No Abstract] [Full Text] [Related]
37. [Transfusion-hemosiderosis].
KOVACS K
Z Arztl Fortbild (Jena); 1956 Mar; 50(5):195-203. PubMed ID: 13338329
[No Abstract] [Full Text] [Related]
38. [Use of desferal and some data on hemosiderosis in hypo- and aplastic anemias].
Fainshtein FE; Trubina NS; Sobaleva IuG; Rozanova NS; Voronina AN
Probl Gematol Pereliv Krovi; 1968 Aug; 13(8):31-8. PubMed ID: 5736846
[No Abstract] [Full Text] [Related]
39. Hemosiderosis in a patient on regular hemodialysis: treatment by desferrioxamine.
Baker LR; Barnett MD; Brozovic B; Cattell WR; Ackrill P; McAlister J; Nimmon C
Clin Nephrol; 1976 Jul; 6(1):326-8. PubMed ID: 954239
[TBL] [Abstract][Full Text] [Related]
40. [PREVENTION OF HYPERACTIVE ERYTHROPOIESIS AS A THERAPEUTIC CRITERION IN THALASSEMIA AND OTHER CORPUSCULAR ANEMIAS. PRELIMINARY NOTE].
REWALD EF
Prensa Med Argent; 1963 Feb; 50():499-500. PubMed ID: 14064391
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
